Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma

Cancer

Volumn 79, Issue 8, 1997, Pages 1516-1520

  Ishii, Hiroshi ^a   Okada, Shuichi ^a   Tokuuye, Koichi ^a   Nose, Haruhiko ^a   Okusaka, Takuji ^a   Yoshimori, Masayoshi ^a   Nagahama, Hiroyasu ^a   Sumi, Minako ^a   Kagami, Yoshikazu ^a   Ikeda, Hiroshi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

chemotherapy; pancreatic neoplasms; prognosis; radiotherapy

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 0030938059     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970415)79:8<1516::AID-CNCR11>3.0.CO;2-0     Document Type: Article

References (13)

1. Moertel CG, Childs DS, Reitemeier RJ, Colby MY, Holbrook MA. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2:865-7.
2. Gastrointestinal Tumor Study Group. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 1981;48:1705-10.
3. Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988;80:751-5.
4. MacMillan WE, Wobery WH, Welling PG. Pharmacokinetics of 5-fluorouracil in human. Cancer Res 1978;38:3479-82.
5. World Health Organization. WHO handbook for reporting results of cancer treatment. Offset Publication 48. Geneva: World Health Organization, 1979.
6. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;63:457-81.
7. Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA, Fryer JG. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program study. J Clin Oncol 1989;7:425-32.
8. Moore M, Anderson I, Burris H, Tarassoff P, Green M, Casper E, et al. A randomized trial of gemcitabine (GEM) versus 5FU as first-line therapy in advanced pancreatic cancer [abstract 473]. Proc Am Soc Clin Oncol 1995;14:199.
9. Lawrence TS, Chang EY, Hahn TM, Hertel LW, Shewach DS. Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine. lnt J Radiat Oncol Biol Phys 1996;34:867-72.
10. Gastrointestinal Tumor Study Group. Radiation therapy combined with Adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic cancer. Cancer 1985;56:2563-8.
11. Whittington R, Neuberg D, Tester WJ, Benson AB, Haller DG. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase 1 Eastern Cooperative Oncology Group trial. J Clin Oncol 1995;13:227-32.
12. Yamaguchi K, Enjoji M. Carcinoma of the pancreas: clinicopathological observations. Jpn J Clin Oncol 1989;19:14-22.
13. Aoki K, Okada S, Moriyama N, Ishii H, Nose H, Yoshimori M, et al. Accuracy of computed tomography in determining pancreatic cancer tumor size. Jpn J Clin Oncol 1994;24: 85-7.